• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人膀胱癌细胞培养物生长的改善。

Improved growth of human urothelial carcinoma cell cultures.

作者信息

Grossman H B, Wedemeyer G, Ren L, Wilson G N, Cox B

出版信息

J Urol. 1986 Oct;136(4):953-9. doi: 10.1016/s0022-5347(17)45139-1.

DOI:10.1016/s0022-5347(17)45139-1
PMID:3761468
Abstract

From January, 1981 through June, 1982 specimens from 21 patients with bladder (urothelial) cancer were placed in tissue culture, and one long term cell line was established (5%). From July, 1982 through February, 1984, using an improved culture medium, seven long term cell cultures were established from 21 patients (33%). In addition, one long term culture from a patient with a bladder melanoma was established using the standard culture medium. The nine cell cultures were derived from the following types of tumors: transitional cell carcinoma (6), adenocarcinoma (1), squamous cell carcinoma (1) and melanoma (1). All of the cell lines have produced tumors in athymic nude mice except for one transitional cell carcinoma. All of the cultures demonstrate aneuploidy. Homogeneously staining regions have been seen in some cell cultures. A common marker chromosome has not been identified.

摘要

从1981年1月至1982年6月,将21例膀胱(尿路上皮)癌患者的标本进行组织培养,建立了1个长期细胞系(5%)。从1982年7月至1984年2月,使用改良培养基,从21例患者中建立了7个长期细胞培养物(33%)。此外,使用标准培养基从1例膀胱黑色素瘤患者中建立了1个长期培养物。这9个细胞培养物来源于以下类型的肿瘤:移行细胞癌(6例)、腺癌(1例)、鳞状细胞癌(1例)和黑色素瘤(1例)。除1例移行细胞癌外,所有细胞系均在无胸腺裸鼠中产生了肿瘤。所有培养物均显示非整倍体。在一些细胞培养物中可见均匀染色区。尚未鉴定出共同的标记染色体。

相似文献

1
Improved growth of human urothelial carcinoma cell cultures.人膀胱癌细胞培养物生长的改善。
J Urol. 1986 Oct;136(4):953-9. doi: 10.1016/s0022-5347(17)45139-1.
2
Characterization of a newly established human urinary bladder cancer cell line (BT-1).一种新建立的人膀胱癌细胞系(BT-1)的特性分析。
Urol Res. 1988;16(1):23-9. doi: 10.1007/BF00264624.
3
UM-UC-1 and UM-UC-2: characterization of two new human transitional cell carcinoma lines.UM-UC-1和UM-UC-2:两种新型人移行细胞癌系的特征描述
J Urol. 1984 Oct;132(4):834-7. doi: 10.1016/s0022-5347(17)49883-1.
4
Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13.源自多倍体人膀胱移行细胞癌UCRU-BL-13的细胞系的特征分析
Int J Cancer. 1989 Aug 15;44(2):276-85. doi: 10.1002/ijc.2910440216.
5
A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure.一株源自膀胱移行细胞肿瘤的人组织培养细胞系:生长、染色体模式及超微结构
Br J Cancer. 1970 Dec;24(4):746-54. doi: 10.1038/bjc.1970.89.
6
Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.在无胸腺裸鼠中作为肿瘤细胞系(R198)维持的人雄激素应答性移行细胞癌的特征描述。
Cancer Res. 1984 Oct;44(10):4560-73.
7
Invasiveness of transformed bladder epithelial cells.转化膀胱上皮细胞的侵袭性。
Cancer Metastasis Rev. 1984;3(3):265-96. doi: 10.1007/BF00048389.
8
Growth characteristics of cultured human normal bladder epithelial cells: a comparison with urothelial carcinoma cell cultures.
Eur Urol. 1988;15(3-4):259-63. doi: 10.1159/000473448.
9
Characterization of a transitional cell carcinoma line arising from a previously irradiated tumor.一株源自先前接受过放疗的肿瘤的移行细胞癌系的特征描述。
J Urol. 1984 Sep;132(3):606-8. doi: 10.1016/s0022-5347(17)49758-8.
10
Establishment and characterization of two human bladder cancer cell lines.两种人膀胱癌细胞系的建立与鉴定
Hum Cell. 1996 Mar;9(1):49-56.

引用本文的文献

1
Rapid formulation of a genetically diverse phage cocktail targeting uropathogenic Escherichia coli infections using the UTI89 model.利用UTI89模型快速构建针对致病性大肠杆菌感染的基因多样化噬菌体鸡尾酒制剂。
Sci Rep. 2025 Apr 14;15(1):12832. doi: 10.1038/s41598-025-96561-y.
2
HOXA13 promotes immune evasion in bladder cancer by suppressing antigen processing and presentation, and phagosome pathways.HOXA13通过抑制抗原加工与呈递以及吞噬体途径促进膀胱癌的免疫逃逸。
Funct Integr Genomics. 2025 Feb 24;25(1):44. doi: 10.1007/s10142-025-01553-w.
3
Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.
新型斑马鱼患者来源肿瘤异种移植方法用于评估免疫刺激卡介苗疗法在膀胱癌中的疗效。
Cells. 2023 Feb 3;12(3):508. doi: 10.3390/cells12030508.
4
Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin.用pH敏感脂质体-吲哚菁绿靶向膀胱尿路上皮癌及用pH敏感脂质体-鹅膏蕈碱抑制尿路上皮癌细胞增殖
Front Urol. 2022;2. doi: 10.3389/fruro.2022.868919. Epub 2022 Aug 24.
5
Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer.组蛋白去乙酰化酶抑制剂通过组蛋白 H2B 赖氨酸 5 的乙酰化来缓解膀胱癌中 PRELP 基因的抑制。
Clin Epigenetics. 2022 Nov 12;14(1):147. doi: 10.1186/s13148-022-01370-z.
6
Response of the Urothelial Carcinoma Cell Lines to Cisplatin.尿路上皮癌细胞系对顺铂的反应。
Int J Mol Sci. 2022 Oct 18;23(20):12488. doi: 10.3390/ijms232012488.
7
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance.膀胱癌细胞中I型干扰素诱导的细胞毒性的分子特征揭示了耐药生物标志物。
Mol Ther Oncolytics. 2021 Nov 12;23:547-559. doi: 10.1016/j.omto.2021.11.006. eCollection 2021 Dec 17.
8
Differences in the Central Energy Metabolism of Cancer Cells between Conventional 2D and Novel 3D Culture Systems.常规 2D 与新型 3D 培养体系中癌细胞中心能量代谢的差异。
Int J Mol Sci. 2021 Feb 11;22(4):1805. doi: 10.3390/ijms22041805.
9
Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models.罗加替尼:一种有效的、选择性的 pan-FGFR 抑制剂,在过表达 FGFR 的临床前癌症模型中具有广泛的抗肿瘤活性。
Int J Cancer. 2019 Sep 1;145(5):1346-1357. doi: 10.1002/ijc.32224. Epub 2019 Mar 13.
10
A surgical orthotopic approach for studying the invasive progression of human bladder cancer.一种用于研究人类膀胱癌侵袭进展的手术原位方法。
Nat Protoc. 2019 Mar;14(3):738-755. doi: 10.1038/s41596-018-0112-8.